The Nutshell

» disease/medicine and genetics & genomics

Daily News Roundup

Most Recent

image: 23andMe Markets Genome Kits to Researchers

23andMe Markets Genome Kits to Researchers

By | July 14, 2016

Scientists can now buy the direct-to-consumer sequencing product, and research participants can join 23andMe’s database.

0 Comments

image: Considering Gene Editing

Considering Gene Editing

By | July 12, 2016

An international committee continues its investigation into the ethical and social considerations of precision DNA editing technology with a public meeting held this morning in Washington, DC.

0 Comments

Ancient DNA research suggests that there were two independent agricultural revolutions more than 10,000 years ago.

1 Comment

image: Treating Cancer with CRISPR?

Treating Cancer with CRISPR?

By | June 17, 2016

A federal panel will review the first proposal for the use of the technology to edit human genes for medical purposes.

0 Comments

image: Mapping Zoonotic Disease

Mapping Zoonotic Disease

By | June 14, 2016

Researchers aim to predict new infectious disease outbreaks that spread from animals to humans.

0 Comments

image: Altered Sense of Touch in Autism?

Altered Sense of Touch in Autism?

By | June 10, 2016

A mouse study suggests that disruptions to nerves in the skin may contribute to autism spectrum disorder.

1 Comment

image: Dog Domestication History Clarified

Dog Domestication History Clarified

By | June 3, 2016

A study suggests that wolves were transformed into man’s best friend more than once, in Asia and in Europe or the Near East.

0 Comments

image: “Human Genome Project-Write” Unveiled

“Human Genome Project-Write” Unveiled

By | June 2, 2016

A proposal to synthesize entire genomes—the subject of a controversial, invitation-only meeting at Harvard last month—is formally presented in Science.

0 Comments

Jazz Pharmaceuticals is set to purchase Celator to acquire an experimental treatment for acute myeloid leukemia.

1 Comment

image: FDA Approves Bladder Cancer Immunotherapy

FDA Approves Bladder Cancer Immunotherapy

By | May 23, 2016

The US Food and Drug Administration greenlights Roche’s Tecentriq, which blocks a protein that obstructs the immune system’s ability to fight cancer.

0 Comments

Popular Now

  1. Publishers’ Legal Action Advances Against Sci-Hub
  2. Decoding the Tripping Brain
  3. Metabolomics Data Under Scrutiny
    Daily News Metabolomics Data Under Scrutiny

    Out of 25,000 features originally detected by metabolic profiling of E. coli, fewer than 1,000 represent unique metabolites, a study finds.

  4. Do Microbes Trigger Alzheimer’s Disease?
AAAS